Company / Operating Margin
ABEONA THERAPEUTICS INC. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-1536.9%
FY2025
5-year range
-3600.8% / -814.2%
FY2021-FY2025
Trend
-14.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -3600.8% in FY2023 to -770.9% in FY2020.
Based on SEC 10-K filings.
-1536.9% in FY2025 with a 5-year CAGR of -766.0%.
Improved from -3600.8% to -1536.9% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +1457.6pp
- 5-Year Change
- -766.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 14.1% year-over-year.
- Peak operating margin was recorded in FY2020.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1536.9% | -14.1% |
| FY2024 | -1346.7% | +62.6% |
| FY2023 | -3600.8% | -20.2% |
| FY2022 | -2994.5% | -267.8% |
| FY2021 | -814.2% | -5.6% |
| FY2020 | -770.9% | +76.8% |
| FY2019 | -3325.7% | -71.4% |
| FY2018 | -1940.2% | +41.7% |
| FY2017 | -3325.7% | -86.5% |
| FY2016 | -1783.3% | -426.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026